Summary
Alphatec product line will expand and increase their market share The cervical plate from Progressive is much more promising than the Trestle plate developed by Alphatec, and should increase sales and improve the cervical implant portfolio
Analysis
Alphatec (NasdaqGM:ATEC) has been adding to its product line with a series of acquisitions and license agreements. I believe the new products such as the Osseo screw and the v-stent technology will help them secure a larger market share. This is likely to directly affect the big players such as Medtroic (MDT:NYSE) and Johnson & Johnson (JNJ:NYSE).
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
